Seung-Beom Han
Biographic Data
| ID | 7305921 |
|---|---|
| NAME | Seung-Beom Han |
| GIVEN NAMES | Seung-Beom |
| FAMILY NAME | Han |
| SIGNATURE | HAN S |
| AFFILIATIONS | Seoul National University |
| ORCID | 0000-0003-1880-4229 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2016 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Efficacy and safety of SKCPT in patients with knee osteoarthritis
SKCPT efficacy was non-inferior, and its safety profile was similar, to celecoxib. Building on previous results showing that SYSADOA reduce NSAID intake, the present results suggest that the SYSADOA SKCPT could effectively replace NSAIDs in knee OA treatment while avoiding long-term side effects
Prospective, randomized, double-blinded, double-dummy and multicenter phase IV clinical study comparing the efficacy and safety of PG201 (Layla) and SKI306X in patients with osteoarthritis
No prominent works on this page.
Prospective, randomized, double-blinded, double-dummy and multicenter phase IV clinical study comparing the efficacy and safety of PG201 (Layla) and SKI306X in patients with osteoarthritis
Efficacy and safety of SKCPT in patients with knee osteoarthritis
SKCPT efficacy was non-inferior, and its safety profile was similar, to celecoxib. Building on previous results showing that SYSADOA reduce NSAID intake, the present results suggest that the SYSADOA SKCPT could effectively replace NSAIDs in knee OA treatment while avoiding long-term side effects
Alternative medicine (2 works) · Clinical trial (2 works) · Double blinded (2 works) · Inflammatory mediators and NSAID effects (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Multicenter study (2 works) · Osteoarthritis (2 works) · Osteoarthritis Treatment and Mechanisms (2 works) · Pathology (2 works)